Rice Hall James & Associates’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-185,958
Closed -$2.95M 263
2023
Q1
$2.95M Sell
185,958
-3,880
-2% -$67.3K 0.17% 144
2022
Q4
$3.57M Sell
189,838
-7,500
-4% -$151K 0.2% 117
2022
Q3
$3.86M Sell
197,338
-46,576
-19% -$1.02M 0.22% 108
2022
Q2
$4.28M Sell
243,914
-92
-0% -$1.67K 0.21% 100
2022
Q1
$4.5M Buy
244,006
+900
+0.4% +$17.8K 0.18% 110
2021
Q4
$5.55M Buy
243,106
+77,526
+47% +$1.57M 0.2% 98
2021
Q3
$3.11M Sell
165,580
-1,276
-0.8% -$26.8K 0.11% 140
2021
Q2
$3.45M Sell
166,856
-6,298
-4% -$122K 0.12% 125
2021
Q1
$2.89M Buy
173,154
+51,985
+43% +$876K 0.09% 150
2020
Q4
$1.79M Buy
+121,169
New +$1.54M 0.06% 211

Other funds holding ADTN

Rice Hall James & Associates's ADTN Position: Q2 2023 in Review

Rice Hall James & Associates sold out of Adtran (ADTN) in Q2 2023, closing a stake of 185,958 shares — an estimated $2.95M sold.

Rice Hall James & Associates first reported a position in ADTN in Q4 2020 and held it in 10 quarters. The position peaked at $5.55M in Q4 2021. 165 funds tracked by Wall St. Rank hold ADTN as of Q2 2023.

  • Rice Hall James & Associates reported no remaining Adtran position as of Q2 2023 after selling out during the quarter.
  • Rice Hall James & Associates sold 185,958 Adtran shares in Q2 2023, an estimated $2.95M.
  • Rice Hall James & Associates first reported a position in Adtran in Q4 2020 and held it in 10 quarters.
  • Rice Hall James & Associates's Adtran position peaked at $5.55M in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Adtran as of Q2 2023.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.